{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pharmacologic Management of Rheumatoid Arthritis


This article has been approved by the Orthopaedic Nurses Certification Board for Category A credit toward recertification as an ONC.

Purpose of Activity

To present information about rheumatoid arthritis, including pathophysiology, risk factors, clinical manifestations, and pharmacologic therapies.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Outline the risk factors, pathophysiology, and clinical manifestations of rheumatoid arthritis.
  2. Summarize the classifications, actions, and dosing protocols of the various drugs used to treat rheumatoid arthritis.
  3. List the contraindications and common adverse effects of the various drugs used to treat rheumatoid arthritis.
Price: $15.00


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Advanced Pharmacology Hours (APH)

Test Code: ON1119C
Published: Nov/Dec 2019
Expires: 12/3/2021
Passing Score: 17/23 (73%)
Authors: Sneha Baxi Srivastava, PharmD, BCACP, CDE; Nicole Fluegel, PharmD; Rupal Patel Mansukhani, PharmD, FAPhA, NCTTP